Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trial

Clinical Biochemistry

Volumn 48, Issue 4-5, 2015, Pages 260-267

  Storrow, Alan B ^a   Nowak, Richard M ^b   Diercks, Deborah B ^c   Singer, Adam J ^d   Wu, Alan H B ^e   Kulstad, Erik ^f   LoVecchio, Frank ^g   Fromm, Christian ^h   Headden, Gary ⁱ   Potis, Tracie ^j   Hogan, Christopher J ^k   Schrock, Jon W ^l   Zelinski, Daniel P ^m   Greenberg, Marna R ⁿ   Christenson, Robert H ^o   Ritchie, James C ^p   Chamberlin, Janna S ^q   Bray, Kurtis R ^q   Rhodes, Daniel W ^q   Trainor, Deirdre ^q   Southwick, Paula C ^q   more..

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ADVOCATE CHRIST MEDICAL CENTER   (United States)

^g MARICOPA MEDICAL CENTER   (United States)

^h MAIMONIDES MEDICAL CENTER   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j Dept of Emergency Medicine   (United States)

^k VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^l METROHEALTH MEDICAL CENTER   (United States)

^m THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

ⁿ LEHIGH VALLEY HOSPITAL   (United States)

^o UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^p EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q BECKMAN COULTER INC   (United States)

more..

Author keywords

Acute coronary syndrome; Biomarker; Chest pain diagnosis; Myocardial infarction; Troponin

Indexed keywords

TROPONIN I; BIOLOGICAL MARKER;

ACCUTNI+3 ASSAY; ACUTE CORONARY SYNDROME; ARTICLE; CARDIAC TROPONIN 1 CLIA KIT; CARDIOVASCULAR DIAGNOSTIC DEVICE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EMERGENCY PATIENT; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEART INFARCTION; HUMAN; IMMUNOASSAY ANALYZER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; THORAX PAIN; BLOOD; CLINICAL TRIAL; MYOCARDIAL INFARCTION; TIME;

BIOMARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; TIME FACTORS; TROPONIN I;

EID: 84924532101     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.09.012     Document Type: Article

References (24)

1. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012, 60:1581-1598.
2. Keller T., Zeller T., Ojeda F., Tzikas S., Lillpopp L., Sinning C., et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011, 306:2684-2693.
3. Reichlin T., Irfan A., Twerenbold R., Reiter M., Hochholzer W., Burkhalter H., et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011, 124:136-145.
4. Wu A.H.B., Jaffe A.S., Apple F.S., Jesse R.L., Francis G.L., Morrow D.A., et al. National academy of clinical biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007, 53:2086-2096.
5. Morrow D.A., Cannon C.P., Jesse R.L., Newby L.K., Ravkilde J., Storrow A.B., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007, 53:552-574.
6. Apple F.S., Pearce L.A., Smith S.W., Kaczmarek J.M., Murakami M.M. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem 2009, 55:930-937.
7. Eggers K.M., Jaffe A.S., Venge P., Lindahl B. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the universal definition of myocardial infarction. Clin Chim Acta 2011, 412:91-97.
8. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 2007, 50:2173-2195.
9. Fesmire F.M., Decker W.W., Diercks D.B., Ghaemmaghami C.A., Nazarian D., Brady W.J., et al. Clinical policy: critical issues in the evaluation and management of adult patients with non-ST-segment elevation acute coronary syndromes. Ann Emerg Med 2006, 48:270-301.
10. CLSI Document I/LA21-A2: Clinical Evaluation of Immunoassays; Approved Guideline 2008, Clinical and Laboratory Standards Institute. 2nd ed.
11. CLSI Document EP24-A2: Assessment of the Diagnostic Accuracy of Laboratory Tests Using Receiver Operating Characteristic Curves; Approved Guideline 2011, Clinical and Laboratory Standards Institute. 2nd ed.
12. Apple F.S., Morrow D.A. Delta cardiac troponin values in practice: are we ready to move absolutely forward to clinical routine?. Clin Chem 2012, 58:8-10.
13. Kavsak P.A., Ko D.T., Wang X., Macrae A.R., Jaffe A.S. Increasing cardiac troponin changes measured by a research high-sensitivity troponin I assay: absolute vs percentage changes and long-term outcomes in a chest pain cohort. Clin Chem 2010, 56:1902-1904.
14. Morrow D.A., Bonaca M.P. Real-world application of "delta" troponin: diagnostic and prognostic implications. J Am Coll Cardiol 2013, 62:1239-1241.
15. Mueller M., Biener M., Vafaie M., Doerr S., Keller T., Blankenberg S., et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012, 58:209-218.
16. Cullen L., Parsonage W.A., Greenslade J., Lamanna A., Hammett C.J., Than M., et al. Delta troponin for the early diagnosis of AMI in emergency patients with chest pain. Int J Cardiol 2013, 168:2602-2608.
17. Bjurman C., Larsson M., Johanson P., Petzold M., Lindahl B., Fu M.L.X., et al. Small changes in troponin T levels are common in patients with non-ST-segment elevation myocardial infarction and are linked to higher mortality. J Am Coll Cardiol 2013, 62:1231-1238.
18. Thygesen K., Mair J., Giannitsis J.E., Mueller C., Lindahl B., Blankenberg S., et al. How to use high sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012, 33:2252-2257.
19. Reiter M., Twerenbold R., Reichlin T., Haaf P., Peter F., Meissner J., et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011, 32:1379-1389.
20. Macrae A.R., Kavsak P.A., Lustig V., Bhargava R., Vandersluis R., Palomaki G.E., et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem 2006, 52:812-818.
21. Aldous S., Pemberton C., Richards A.M., Troughton R., Than M. High-sensitivity troponin T for early rule-out of myocardial infarction in recent onset chest pain. Emerg Med J 2012, 29:805-810.
22. Diercks D.B., Peacock W.F., Hollander J.E., Singer A.J., Birkhahn R., et al. Diagnostic accuracy of a point-of-care troponin I assay for acute myocardial infarction within 3hours after presentation in early presenters to the emergency department with chest pain. Am Heart J 2012, 163:74-80.
23. Biener M., Mueller M., Vafaie M., Keller T., Blankenberg S., White H.D., et al. Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population. Int J Cardiol 2013, 167:1134-1140.
24. Apple F.S., Smith S.W., Pearce L.A., Murakami M.M. Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay. Clin Biochem 2012, 45:711-713.